Bill Paton was a scientist and scholar of rare distinction. He made his mark not only by his own contributions to pharmacology and medical science, and by his abilities as an administrator and head of department, but also through his influence on public policy. He was much in demand for committee service because of his ability to get to the root of difficult problems and to achieve consensus on controversial issues. He enjoyed taking on these responsibilities and took them very seriously. For him, forming an opinion was something to be done only after he was fully in possession of the facts and the history of the problem. He was also a very kind and generous man, and lacked any trace of intellectual arrogance. Knowledge was to him something to be used to pave the way to a better human future, rather than to bolster his own esteem. Though his talents took him quickly to the top, he remained an unostentatious person with a modest lifestyle, devoid of the trappings and affectations which often accompany success. His many friends and colleagues owe a lot to his support and guidance, and to the example that he set. E a r l y y e a r s a n d f a m il y b a c k g r o u n d
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Figure 5 scholarship to Repton School. At that time the headmaster was Geoffrey Fisher, later Archbishop of Canterbury. He thought that Paton was going right off the rails when he opted to study medicine rather than the classics at university. But that very rationality that led him to agnosticism had clearly bred the scientific curiosity that now motivated him. In 1935 he won the Theodore Williams scholarship to New College, Oxford. To this he added the Christopher Welsh scholarship and the Jesse Theresa Rowden scholarship. He emerged with a First Class Honours degree in physiology in 1938. He completed his medical training at University College Hospital, London, where in 1938, he won the Goldsmid exhibition. He continued to show real brilliance in his clinical studies. He was much influenced by Max Rosenheim, then the Professor of Medicine, and he won the Gold Medal in clinical medicine in 1941. One of his contemporaries at U.C.H. was John Gray, later to be a colleague at the National Institute for Medical Research, who remembers him as a brilliant student.
In 1942 he graduated B.M.,B.Ch. (Oxon). While at U.C.H. Paton became editor of the U.C.H. magazine. As a medical student he spent time working in the casualty department. Here he met an almoner, Phoebe Rooke, who had an office in the outpatient department. He and Phoebe were often on duty together waiting for the admission of the inevitable air raid casualties. He invited her to write an article on social medicine for the U.C.H. magazine and by the time he graduated, he had asked her to marry him; the deed was done in 1942. Although they had no children, theirs was an extremely successful and happy union which was to last until Bill's death in 1993.
Bill was unfit for the armed services and the stresses of life in clinical medicine would almost certainly have been too heavy for anyone with his physical incapacity. After completing his house physician's job he worked for two years as a pathologist at the King Edward VII Sanatorium, until in 1944 he took the most critical decision of his entire career when he accepted a job at the Medical Research Council laboratories in Hampstead.
T h e M e d ic a l R e se a r c h C o u n c il la b o r a to r ies Bill joined the M.R.C. laboratory in Hampstead to work on problems relating to diving and submarine escape, which were part of the M.R.C.'s wartime brief. This was the start of his lifelong interest in the effects of high pressure on physiological systems. He joined a group of highly talented physiologists and pharmacologists which included J.B.S. Haldane, K.W. Donald, F. Dickens and H.R. Barlow. The team was led by G.L. Brown, who had succeeded the legendary Henry Dale as Head of Physiology in Hampstead. For a young man just embarking on a research career the ambience of extreme intellectual brilliance must have been both stimulating and frightening. Brown obtained from the Lister Institute the pressure chamber that J.S. Haldane had used a generation earlier for the research that led to the first reliable analysis of the principles of decompression sickness, and to the tables used to determine the maximum safe rate of decompression. Brown and his associates began to gain experience in doing human experiments under pressure. Fortunately the experiments led to no serious accidents, but there were some near misses. On one occasion, during an experiment on the narcotic effect of breathing carbon dioxide mixtures in an experimental booth, Paton lost consciousness, and was rescued by a passing cleaner who had the presence of mind to break the glass. Paton's interest in hyperbaric physiology was never lost, but when the war ended the Hampstead laboratory resumed the work begun by Sir Henry Dale, giving Paton his first taste of pharmacology.
The M.R.C. building in Hampstead had been a hospital and the main physiology laboratory was in a former ward; the fourth room on the first floor, it was known internationally as F4. In it Dale had done much of his classic work with Feldberg, Vogt and Gaddum; and the traditions of that period were still maintained by Dale's former technician, L.G. Collinson, now the head technician. With G.L. Brown in charge there was a light-hearted atmosphere. There would be three or four experiments going on in the one laboratory at the same time. Colleagues would drop by to watch for a few moments, to comment, to advise, to criticize and, if requested, to help. Long interludes in which there was nothing definite to do, ostensibly to 'allow the preparation to settle down' seemed to be a conspicuous feature of the F4-style of work. Each member of staff was left to decide his own line of work and to stand on his own feet. There was no question of being directed to work on a particular problem. During the period Paton worked with McIntosh, Zaimis, Gray, Feldberg, Burns, Perry and Vianna Dias.
The period from 1946, when Paton first began research, to 1952 was extraordinarily productive. He was in his early 1930s, working simultaneously in three quite distinct areascholinergic transmission, diving and histamine release -and making major discoveries in all three. His international reputation was growing rapidly. He was happily married to a wife who tolerated his unrelenting appetite for work, and, not surprisingly, he looked back to these years with fondness and nostalgia. Having supposed that his future would lie in respiratory physiology, he had had his eyes opened to the appeal of pharmacology, and managed to keep close to the forefront in both fields for the rest of his working life.
The National Institute for Medical Research remained in Hampstead until late in 1949 when it moved to the new building at Mill Hill which had been completed before the war. The intimacy was lost in Mill Hill. In a memoir years later, Paton quotes a remark made by W. A.H. Rushton: 'Moving to a larger laboratory is like adiabatic expansion: the particles become more distant from each other, and the temperature falls', precisely the kind of analogy of which he was most fond. Amongst others, Paton grew restless, and in 1952 he decided to move to a readership at University College Hospital, a post recently vacated by Andrew Wilson, who had moved to the chair of pharmacology in Liverpool. U.C.H. a n d t h e R oyal C o l l e g e o f S u r g eo n s The U.C.H. position was an unusual one, in that it was a joint appointment between the Medical Unit, headed by M.L. Rosenheim, and the Department of Pharmacology at University College, London, headed by F.R. Winton. It was the juxtaposition of the basic and the clinical aspects of pharmacology that was attractive to him, as well as the appeal of working alongside Rosenheim, a scientifically minded clinician whom Bill greatly admired. At this time a very fruitful collaboration, and close friendship, with J.W. Thompson began. Thompson was a clinician with no formal scientific training, but with a strong leaning towards research. Somewhat at a loss over what to do next, and feeling nervous because of his lack of scientific qualifications, he went to see W. Feldberg at Mill Hill, who took him down the corridor to meet Bill Paton. Paton told him that he should regard the lack of scientific training as a positive advantage, as he would be able to embark on research with an open mind, and it was quickly arranged that Thompson should join the new laboratory at U.C.H. Their first year was spent mainly in setting up new laboratories in both Departments, and Thompson's flair for electronics and instrumentation was a great asset. Paton, surprisingly for one who showed a seemingly effortless command of mathematics and physical sciences, was ill at ease with electronics and measuring equipment. Though they were working in a clinical department, their approach could in no way be described as clinical pharmacology, as their experiments were based almost entirely on anaesthetized cats and isolated organ studies. Rosenheim was quite happy about this; he liked human disease to be represented in the projects going on in his department, but supported the use of non-clinical approaches. Nevertheless, he did his best to involve Paton in the clinical work of the unit. This was largely unsuccessful, for Paton found ward rounds an effort. He introduced a very successful bridging course in pharmacology for clinical students, designed to link their basic preclinical pharmacology to therapeutics. This was a novel concept in the days before clinical pharmacology was established as a discipline in its own right. Unfortunately, John Thompson's introduction to experimental research led quickly to a dead-end, one of the few in Paton's research career. They decided to investigate the effect of porphobilinogen, a metabolite produced in excess in patients with porphyria, on the cardiovascular system, but their initial positive results proved to be an experimental artefact. One of Paton's initiatives at U.C.L. was the introduction into the preclinical practical classes, hitherto very animal-oriented, of two experiments in which students recorded the (sometimes dramatic) effects of drugs on themselves. These classes took on a legendary quality at U.C.L., and continued for many years after Bill Paton's departure, until they eventually had to be discontinued because of the changing climate of opinion about the ethics of experiments on student volunteers.
After only two years at U.C.H., Paton was invited in 1956 to move to the Royal College of Surgeons in Lincolns Inn Fields, where a new department of pharmacology was being set up to complement the existing departments of physiology, biochemistry and pathology. The aim of the college was to build up a strong research base, and also to provide teaching at a postgraduate level for trainee surgeons and anaesthetists. It was particularly to meet the needs of the latter group that the pharmacology department was established. Bill agonized considerably about moving from one of the best medical schools in country to a new department in an unfamiliar institution.Though he had not faced any major difficulties at U.C.H., he was attracted by the idea of setting up his own department from scratch, and became the first Vandervell Professor of Pharmacology at the Royal College of Surgeons. He was joined by John Thompson, who again bore much of the brunt of setting up new laboratories.
Bill enjoyed the freedom and support that he had at the Royal College of Surgeons, and the department prospered. The permanent staff included J.R. Vane and J.E. Gardiner, and the group quickly attracted research fellows of very high calibre, mainly from the clinical world. The friendly and productive nature of the department, styled somewhat on the nosy and gossipy atmosphere of the communal M.R.C. laboratories at Hampstead, was exactly what he had missed in the more formal and hierarchical organization at U.C.H. To enable him to carry out his duties as head of department while at the same time continuing with hands-on experimental work, he developed the habit of running experiments in his office. This habit stayed with him throughout his working life, and he always made sure that his office included a stretch of bench and the necessary services to allow him to do experiments on isolated tissues. The equipment was generally quite ramshackle. Things were kept warm by a noisy thermostatic circulator, liable to cause floods when ancient pieces of rubber tubing gave way. Until this time, nearly all of Paton's experimental work had been done with whole animals under anaesthesia. Working with isolated tissues in an organ bath was therefore a considerable change, which led to a highly productive phase in Paton's research career.
The isolated ileum preparation taken from the guinea-pig was, and still is, widely used for the analysis of the action of drugs on smooth muscle. It is convenient because it can be maintained for many hours suspended in physiological saline and will contract in a reproducible and graded manner in response to appropriate drugs. Paton, in response to a request to give a lecture on the neural control of the intestine (a topic on which he had not previously worked), quickly adapted this preparation by installing coaxial stimulating electrodes into the bath. An electrical stimulus would cause a brief contraction of the muscle, and Paton was able to show that this resulted not from direct stimulation of the smooth muscle fibres, but from stimulation of the intramural nerve plexus which forms a network adjacent to the muscle layer. Excitation of the nerve plexus causes the release of transmitters, mainly acetylcholine, which act on receptors on the smooth muscle cells to cause them to contract. This has proved to be an extremely valuable technique for studying the factors that control the release of acetylcholine from autonomic nerve endings. It served Paton's needs exactly, because it was ideally suited for the comer of his office, and would mn for hours with minimal attention.
Paton used this technique to investigate the actions of morphine, a substance used clinically as a powerful analgesic agent. At this time, although the actions of morphine in animals and humans had been documented in great detail, very little was known about its actions on cells and tissues. Paton found that low concentrations of morphine strongly inhibited the contraction of the tissue produced by electrical stimulation, without affecting the inherent contractility of the smooth muscle, implying that it could inhibit the release of acetylcholine from the nerve plexus. Moreover, if the preparation was exposed continuously to morphine for an hour or more, the contraction tended to return, and when the morphine was washed away, the muscle went into a state of hyperactivity and spasm, events which paralleled the phenomena of morphine tolerance and dependence that were well known clinically. This was the first time that morphine dependence had been observed 'in the test-tube', and these studies paved the way for much more detailed analysis of the mechanisms underlying morphine action and morphine dependence. The coaxially stimulated ileum preparation was later taken up and adapted to other tissues by H.W. Kosterlitz and his colleagues in Aberdeen, whose studies led to an important re-classification of opiate receptors. The realization that many of the effects of morphine are attributable to inhibition of neurotransmitter release in the central nervous system stems from Paton's original observations on the guinea-pig ileum. Paton's first and only paper on this subject (7)*, published in the British Journal o f Pharmacology in 1957, became a Current Contents 'Citation Classic' in 1989, as it became so widely quoted by the growing army of opiate researchers during the 1970s and 1980s. With John Vane, he also used the same technique to study the neurochemical transmission in the stomach.
Paton was elected a Fellow of the Royal Society in 1956. He was also very active at this *Numbers in this form refer to the bibliography at the end of the text.
time in the high-profile role of Secretary of the Physiological Society. The College was proud to have him and his department within their establishment, and supported them generously. Through his earlier work on decamethonium and neuromuscular blocking agents, Paton had many contacts with anaesthetists, and these developed further at the Royal College of Surgeons. One of his research fellows was J.P. Payne, who later became Professor of Anaesthetics at the College and collaborated with Paton in writing a student textbook, Pharmacological Principles and Practice (9), published in 1968. This scholarly and interesting book placed great emphasis on the use of actual experimental data, obtained in man wherever possible, to illustrate the principles of pharmacology as applied to medicine. Unfortunately, it was too basic in its treatment for the average clinical student, and too humanoriented for the average preclinical student. It expressed very well Paton's concern to link therapeutics with the kind of basic pharmacology taught in preclinical courses, but was perhaps too far ahead of the current teaching practices, and achieved only a limited success.
Bill clearly had in mind the possibility of succeeding J.H. Bum as Professor of Pharmacology in Oxford on Bum 's retirement in 1959, a date which coincided with the end of the agreed five years of funding for the laboratories at the Royal College of Surgeons. Despite solemn advice that one should not apply for such a post in Oxford, but rather wait to be asked, he did apply, and was elected. The Oxford department had, during Bum's tenure, become the most distinguished pharmacology department in the United Kingdom. Among its six permanent faculty members, no fewer than four were Fellows of the Royal Society, namely Hugh Blaschko, a biochemist noted mainly for his work on monoamine metabolism, Raymond Ing, a chemist who had conceived and synthesized the quaternary ammonium compounds studied earlier by Paton, Zaimis and others, Edith Bulbring, noted for her work on the electrophysiology of smooth muscle, and Bum himself, whose reputation was based mainly on his analysis of the action of drugs on the sympathetic nervous system. The other two faculty positions were held by John Walker, who worked on posterior pituitary peptides, and Miles Vaughan Williams, one of the pioneers of cardiac electrophysiology and the actions of antiarrythmic drugs. Ing was nearing retiring age, and neither Bulbring nor Blaschko was prepared to take on the administrative and teaching duties of the head of department, and the Department seems to have been unanimous in its approval of Bill's appointment to the chair.
As far as both research and teaching were concerned, the Department was mnning very successfully when Bill arrived, and he did not seek to impose any sudden changes. The teaching programme for medical students had as its centrepiece a very comprehensive practical class in which all the members of staff played an active part, and Bill was keen to see this continue with minimal change. His immediate task, on arriving in Oxford, was to organize the design and constmction of a large extension to the old pharmacology building, which had been planned and approved during Bum's chairmanship. This took up most of Bill's time in his first year, and the resulting building provided excellent research, teaching and workshop facilities, which served the Department well for the next 30 years, and was a pleasure to work in.
Soon after arriving in Oxford, Bill was introduced to a physical chemist, Brian Smith, who was interested in the mechanism of action of gaseous anaesthetic agents. Smith had acquired this interest during a spell in Berkeley, California, where he had worked with J.H. Hildebrand. Through his experience in diving and hyperbaric physiology, Bill was interested in the possible narcotic effects of respiratory gases, nitrogen, oxygen and carbon dioxide, and more generally in the mechanism of the narcotic action of simple volatile and gaseous compounds. Brian Smith recalls that the first meetings between him and Paton were somewhat unpromising; Paton was unimpressed by Smith's understanding of physiology. The reserve was quickly overcome, however, and they decided to collaborate and formed a High Pressure Group. This was a distinctly unusual enterprise for a professor of pharmacology, and the Oxford Department of Pharmacology was certainly not used to the industrial atmosphere of the High Pressure Laboratory on the ground floor. Several heavy-duty pressure chambers were installed in the laboratory; because of their weight, they had to be moved around with an overhead gantry and chain hoists. They were fitted with impressive brass pressure gauges, and were coupled by tangled arrays of copper pipework to a battery of very large gas cylinders.
To the members of the Pharmacology Department, used to dealing with more delicate and fragile (and much less noisy) equipment, it seemed like a return to the age of steam. For Paton, the early days of the High Pressure Group brought back something of the atmosphere and excitement of the old Hampstead laboratory which he had enjoyed so much. The enthusiasm and energy of Brian Smith, and the support of a series of very able students, mostly with a chemistry background, carried the work along very quickly. Paton and Smith arranged to work in the laboratory every Thursday, and most Thursdays they managed to discover something new and unexpected. The students and research fellows who worked in this group included Keith Miller (later Malinckrodt Professor at Harvard), John Lever, Roger Pertwee, Michael Halsey, Steve Daniels, Sheldon Roth, Hilary Little and Frank Bowser-Riley, all of whom have continued to make independent contributions in related fields of pharmacology.
Paton's second major initiative at Oxford was to set up a research group to study the pharmacology of cannabis. In describing the background to this, he refers to it as one of the two issues on which 'I was pushed out of the purely academic path'. At a meeting in 1966, he had learned of evidence purporting to link heroin addiction to earlier cannabis use. At the same time, the Wootton Committee had recommended a relaxation of the legal restrictions on cannabis use, on the basis that there was no evidence that it was inherently harmful or addictive. Paton felt strongly that available information was being ignored, and also that there was an urgent need for more detailed pharmacological studies on cannabis, and this led in 1969 to him setting up the group in Oxford, with support from the Medical Research Council and the Wellcome Trust.
The Chair of Pharmacology in Oxford carried with it a professorial fellowship at Balliol College. He valued this greatly, even though he was not by nature a clubbable individual, and tended to stay outside the intricate and passionate politics of the college system. On Bill's retirement, the attachment of the Chair of Pharmacology was transferred from Balliol to Lady Margaret Hall. This was agreed to by Balliol, as the college had acquired more than its fair share of professorial fellows, and it seemed right to distribute them more evenly. Bill was, however, deeply offended by this decision, which permanently marred his relationship with the College in spite of attempts to make amends.
Until the early 1970s pharmacology was taught in Oxford only as a part of the medical curriculum and as a special course for chemists. Biology students were not taught any pharmacology. Paton was successful in changing this when the curriculum was revised in 1971. At that time, a series of third year options for science students was introduced, including an option in pharmacology, along with others in different aspects of physiology, biochemistry, immunology, etc. The pharmacology course quickly became the most popular option on the list, and the teaching resources of the Department became distinctly overstretched. Through this, Paton successfully argued for an increase in the teaching staff, and for a further extension to the building. He had already foreseen the time when the department would grow beyond the capacity of its site on the north side of South Parks Road, and successfully persuaded the University to earmark a larger site on the other side of the road for a new and larger building. After Paton retired, his successor, David Smith, was able to raise the money to put this plan into effect, a development which gave Paton much satisfaction. Bill Paton's cool and non-prescriptive approach to running a research laboratory, supplemented by his own largely solo efforts, proved to be a very successful formula, and was initially very productive, though it was perhaps less appropriate later, when his interests turned to cannabis research. His own range of technical expertise was based on the classical pharmacological methods pioneered by Dale, very effective for identifying and defining a new problem, but lacking the power of more modem cellular, molecular and chemical techniques. The technical expertise and equipment was all in place within the cannabis group, but the group needed strong leadership and co-ordination to make it work as a team, and this was not Bill's strong suit.
W e l l c o m e In s t it u t e
Shortly before his retirement from the chair in Oxford, Bill Paton became Acting Director of the Wellcome Institute for the History of Medicine, taking over after the retirement of Peter Williams. The Wellcome Institute was housed in the Wellcome Building in Euston Road, and comprised an outstanding library, as well as an Academic Unit; a significant proportion of the Trust's funds are devoted to it. With his longstanding interest in books and medical history, Paton had, during his many years as a Wellcome Trustee, been a strong supporter of the Institute and its work, sometimes to a degree that went beyond the inclinations of his fellow Trustees. It was not easy to find candidates for the Directorship who were accomplished both as medical scientists and as medical historians, as well as possessing the administrative skills that the job needed. Bill did not need much persuading, even though he had reached the retiring age of 67 and his health was not good. He took up his new duties in October 1983 with his typical quiet but strong enthusiasm, travelling daily from his home in Oxford to his office in the Wellcome Building. The Institute was run very effectively by the senior staff, and what was needed at the top was a person of the appropriate gravitas and experience to resolve any disputes that might arise, and to act as a respected spokesman to represent the Institute's interests to the Trust and in the public domain. Bill's approach, typically, was to work, not by dirigisme, but by making himself readily available, and by ensuring that he knew all of the staff and what they were doing. The result was a very happy period for the Institute, in which the senior members were encouraged to run its day-to-day affairs in their own way, while everyone gained from the feeling that a highly respected member of the medical science establishment showed such a personal enthusiasm and support for their work. Professional historians are not always tolerant of enthusiastic amateurs, and it says much for Bill's scholarship and diplomacy that the arrangement worked so well. Towards the end of his tenure, when his health was failing, Bill found it hard to make the journey to London, and the meetings would be held at his home in Oxford, with 'committee tea' provided by Phoebe. These teas were said to be not just the high spot of, but perhaps the excuse for, much Institute administration. He was succeeded as Director by Eric Freeman, the Librarian.
S c ie n t if ic a c h ie v e m e n t s

The methonium compounds
The first publication on the methonium compounds was a short note by Paton and Zaimis (1) in Nature in May 1948, describing the curare-like action of decamethonium (CIO) in the rabbit and cat: '... before clinical application can be considered it is desirable to find some satisfactory antagonist to their effects'. In November. 1948, they published another Nature note (2) on 'The clinical potentialities of certain bisquaternary salts causing neuromuscular and ganglionic block', and in January 1949, there appeared a report in the Lancet (3) of the neuromuscular blocking effect of CIO, and the cardiovascular effect of C5 on the three authors (Paton, Zaimis and Organe, an anaesthetist). Clinical trials in patients were reported in the same year, and the result was that within a few years both decamethonium and hexamethonium (C6) were introduced into clinical use. In one classic paper, published in the British Journal o f Pharmacology in 1949 (5), the actions of the whole series of methonium compounds, from C3 to C l2, were described and analysed in detail. Paton and Zaimis realized from the outset that the action of decamethonium at the neuromuscular junction was fundamentally different from that of the well known blocking agent tubocurarine, in that it produced an initial transient excitation of the muscle, and also caused a depolarization of the muscle not seen with tubocurarine. Furthermore, the blocking effect of tubocurarine could be reversed by administration of an anticholinesterase drug, whereas that of decamethonium could not. These differences led Paton to the idea of 'depolarization block' which was most elegantly confirmed in a study published jointly with B.D. Bums in 1951 (6) . By recording with electrodes applied to the surface of the muscle, they showed that decamethonium did indeed cause a local depolarization confined to the endplate region, leading to a gradual loss of electrical excitability of that region of the muscle fibre. The same effect could be obtained by artificial depolarization of the endplate region of the muscle with a cathodic current, whereas artificial repolarization of the fibres, by passing an anodic current, was able to restore transmission when it had been blocked by decamethonium.
Hexamethonium, though less unusual in its pharmacological mechanism of action, was of even greater clinical importance than decamethonium. At the time of its discovery, the only known ganglion blocking drug (apart from nicotine, whose main effect on autonomic ganglia was excitatory) was tetraethylammonium, a drug with many side-effects and other undesirable properties. There was a real need for a more potent and selective drug for use in the treatment of hypertension, a disease which, in the late 1940s, carried an extremely poor prognosis. Hexamethonium, given subcutaneously, became the standard drug for treating severe hypertension. Even though it had major drawbacks in the form of unpleasant side-effects, such as constipation, blurred vision and fainting, it was effective in prolonging life, and had opened the door to the drug treatment of hypertension. Although superseded in the late 1950s by drugs which act selectively on adrenergic nerve terminals, and therefore have fewer side-effects, hexamethonium represented an important therapeutic landmark.
Histamine release
Paton's interest in histamine began in 1947, when he and Macintosh were asked to investigate the mechanism by which a new antibiotic substance, licheniformin, unexpectedly caused a fall in blood pressure in experimental animals. What they noticed was that licheniformin given intravenously caused the blood pressure to fall suddenly and transiently after a short delay, whereas other vasodilators, such as acetylcholine or histamine, acted immediately. Suspecting that it must be acting indirectly, by liberating a vasodilator substance from blood or tissue sources, they were able to show that blood from a cat injected with licheniformin caused an immediate blood pressure fall when injected into a second animal. The substance liberated was then shown, by a variety of pharmacological tests, to be indistinguishable from histamine. In the first publication (4), in 1949, they tested no fewer than 64 compounds for this novel action, and showed that many basic compounds in addition to licheniformin had the same effect. Later they discovered that compound 48/80, a phenylethylamine condensation product discovered accidentally as a contaminant in the synthesis of isoquinolines, was a particularly powerful histamine releaser, and this compound is still used as a standard in tests for histamine release. Later work, mainly by Riley and others, showed that much of the histamine in tissues resided in mast cells, and that releasers such as 48/80 produce a dramatic effect on these cells, causing their histamine storage granules to be discharged. As the same effects are produced by clinically used drugs such as morphine or tubocurarine, Paton suggested that some of their unexplained side-effects, such as itching, hypotension and bronchoconstriction, might be due to histamine release. Paton continued to write on the subject for several more years, but his own experimental contributions, which had opened up this new field, effectively came to an end after 1951.
The rate theory o f drug action
As so often happened, it was an invitation to speak at a meeting that stimulated Paton to develop a new idea about drug action at the receptor level. His earlier work on the methonium compounds had shown that transmission block at cholinergic synapses could occur by distinct depolarizing and non-depolarizing mechanisms. But there was also accumulating evidence that drugs could produce an intermediate type of 'dual block', where an initial depolarizing block gradually gave way to a non-depolarizing block. The action of nicotine on autonomic ganglia, elucidated by Paton and Perry, was one such example. In 1955, Paton started one of his many notebooks on the subject of receptor theory, following the work of A.V. Hill, A.J. Clark, J.H. Gaddum, H.O. Schild and R.P. Stephenson, who had set out the physicochemical basis for drug-receptor interactions in terms of the law of mass action. They had mainly confined themselves to the equilibrium relationship between drug concentration and receptor occupancy, and only Stephenson had much to say about the distinction between agonists and antagonists. These authors all assumed that the agonist effect of a drug was directly related to receptor occupancy, and that this relationship was different for agonists and antagonists. Paton felt that kinetic factors had somehow to be taken into account, as there was evidence that an agonist effect (the phase of depolarization block), could fade with time and be replaced by antagonism (the phase of non-depolarizing block), and that this kinetic process was at the root of the dual block question. Paton's brainwave, which came while he was doodling with mass action equations during a period of convalescence, was that the agonist effect of a drug corresponded with the moment of association with the receptor, and that its continuing occupancy of the receptor only resulted in block, because it prevented further associations from taking place. Thus rate of association determined the agonist effect of a drug, and occupancy determined its antagonist effect. When the drug is first applied, the rate of association will be at its maximum, and it will then decrease as the number of vacant receptors becomes less. In principle, all drugs that bind to the receptor will be agonists, but unless the drug-receptor complex dissociates rapidly, so as to allow further associations, the agonist effect will decline very rapidly, and may be too transient to be observed. The critical parameter that distinguishes agonists from antagonists is therefore the rate of dissociation of the drug-receptor complex. The analogy which Paton coined to distinguish the rate theory from the conventional occupation theory was that of piano and organ. When a piano key is struck, it makes a transient sound, and holding the key down prevents the hammer from operating again. In contrast, the organ makes a sound that lasts as long as the key is pressed. (This pleasing analogy caused John Vane later to describe an experimental set-up as 'what I understand we must now call an isolated piano bath'.) One implication of the rate theory was that the dissociation rate constant for agonists should always be much greater than that for antagonists, and Paton set out to test this by measuring the rate of recovery of tissues from the effects of agonists and antagonists. This bold theory and supporting experimental data were published in 1961 (8). This paper gained much attention, as it offered a tangible account of why some drugs are agonists and others are antagonists, a departure from the abstract algebraic approaches which preceded it. However, it was never clear exactly what physical mechanism could be involved. Subsequent work has discredited the rate theory, partly through results from Paton's own laboratory showing that the rate of equilibration of drugs with the receptors is generally governed by diffusion, and cannot therefore be used to estimate the intrinsic association and dissociation rate constants. More recent studies on the opening of single membrane channels in response to agonists such as acetylcholine have also shown that occupancy, rather than association rate, determines the opening probability. Though the theory itself turned out to be wrong, Paton's 1961 paper produced a resurgence of interest in receptor mechanisms. Soon after, from Paton's laboratory, the first comprehensive analysis of drug binding to receptors, measured directly with radioactively labelled drug, was published, and this was the forerunner of the work which allowed others to study receptors directly with biochemical techniques. Paton himself was a little discouraged that the rate theory did not after all represent the conceptual breakthrough that he had hoped for, and soon turned his attention to other problems.
Diving, hyberbaric physiology and anaesthesia
Paton's earliest work, carried out with G.L. Brown's group at Hampstead, was concerned with various aspects of submarine escape from the point of view of respiratory physiology. One question of concern was the optimal inspired air pressure to be delivered by the breathing apparatus used by a subject immersed in water, and therefore subjected to a different hydrostatic pressure at the base and apex of the lungs. Taking into account the complex physiological factors involved, Paton concluded that the apex pressure represented the best compromise.
He also studied the factors needed for successful free escapes from submarines. To avoid lung collapse as the subject moves from the low pressure of the submarine interior to the high pressure of deep water, the subject must fill his lungs with air at high pressure. Then, as he ascends, and the pressure falls, he must allow the expanding air in his lungs to escape, so as to avoid 'burst lung'. The escaping air also has the important function of carrying away carbon dioxide, allowing the subject to hold his breath for much longer than is possible under isobaric conditions. Paton characteristically planned and analysed the experimental work on these very practical questions on the basis of a thorough working-out of the quantitative theory of respiratory gas exchange, set out copiously and meticulously in his early notebooks. Other topics on which he worked at this time included the pharmacological effects of excessive amounts of the main respiratory gases, oxygen and carbon dioxide. This led to the definition of the safe limits for breathing air containing increased amounts of carbon dioxide -an important factor in a closed environment such as a submarine -and of oxygen at hyberbaric pressures, which allowed the setting of a depth limit for divers breathing pure oxygen. He wrote, for the Admiralty, the official manual for naval medical officers, covering many aspects of underwater physiology, including submarine escape and the problems encountered in diving. This, like much of the large body of experimental work underlying it, was a restricted publication, and Paton's important contributions were largely unrecognized by the general scientific community.
Decompression sickness was another problem on which Paton worked throughout his scientific career. The phenomenon of decompression sickness ( 'bends' and later arthritic complications) among workers constructing underwater tunnels, was recognized in the nineteenth century. These workers normally stayed at pressures of 3-5 atmospheres for shifts lasting a few hours. The underlying cause was known to be bubble formation in tissues and blood vessels on decompression as the dissolved nitrogen that had accumulated during the shift came out of solution. The first detailed analysis, on the basis of gas solubilities, diffusion rates, blood flow and respiratory gas exchange, was carried out by J.S. Haldane, A.E. Boycott and G.C.C. Damant, and this resulted in the first reliable decompression tables, published in 1908, which prescribed the acceptable rate of decompression as a function of the pressure and time of exposure. These procedures were intended, by avoiding supersaturation of the dissolved gas by a factor exceeding 2, to prevent bubble formation. They were adopted as obligatory practice for tunnel and caisson workers.
As a member of an M.R.C. Committee on decompression sickness, Paton carried out two major epidemiological studies, the first on workers on the Tyne Tunnel project in 1946-48, and the second during sinking of caissons in the Thames in 1950. These established clearly the incidence and nature of decompression sickness under conditions in which the Haldane decompression procedures were used, and it was shown that these procedures were not sufficient to avoid acute and long-term effects. In particular, it was discovered that 'acclimatization' occurred to a marked extent, so that protection against decompression sickness developed after repeated sessions of work at high pressure. This and other factors, including more conservative limits on the pressure and duration of exposure following which controlled decompression was required, were incorporated in the modified decompression tables officially adopted in 1951. The M.R.C. Decompression Panel was set up in 1951 under Paton's chairmanship, and was responsible for drafting the official regulations applying to civilian diving operations. Its members included H.V. Hempleman and D. Walder. A similar group, also chaired by Paton -the Underwater Physiology Subcommittee of the Royal Naval Personnel Research Committee -was responsible for the regulations concerning naval diving operations.
The High Pressure Group at Oxford remained very productive from its inception in 1965 throughout Paton's time as professor, and it continued under Brian Smith's leadership for several more years after Paton's retirement in 1984. Its work ranged broadly over four main themes, related very much to the practical problems of diving and decompression to which Bill had been introduced at the outset of his research career. It was the kind of applied research, closely aligned to solving practical problems, which he most enjoyed, with ample scope for applying simple quantitative theory. The themes on which the group worked were: decompression sickness; mechanisms of anaesthesia, particularly by gases at high pressure; and the effects of high hydrostatic pressure per se on physiological systems.
Ways of avoiding decompression sickness, and of reducing the time needed for controlled decompression after sea-dives, were a subject of active research by the Oxford group. The use of helium by divers, in place of nitrogen, had been introduced many years earlier, its advantage being that it is much less soluble in tissues than nitrogen, so that less is taken up by the tissues. It is also less viscous, an important factor in breathing at high pressure. Helium-oxygen mixtures, however, tend to produce high-pressure convulsions, more readily than nitrogen-oxygen mixtures. The Oxford group showed that this was because nitrogen at high pressure produced a narcotic effect, whereas helium did not, The narcotic effect was able to stave off the convulsant action of high pressure. This discovery led to the development of 'Trimix', in which 10 per cent nitrogen was added to the helium-oxygen mixture, which was widely used during North Sea oil explorations to allow divers to work at greater depths than were possible with helium-oxygen alone.
Another important study carried out at Oxford was on the 'double-dive' phenomenon. An initial asymptomatic compression-decompression cycle was found to increase greatly the incidence of symptoms produced by a subsequent 'test dive'. In a very elegant series of experiments, the group showed that this was due to the presence of small gas bubbles forming in the arteries during the first decompression. On recompression, these 'silent bubbles' shrank and moved to the venous system, becoming trapped in the lungs. Their expansion at this site during the second decompression was responsible for the much more severe physiological effect. This was an important experiment for two reasons. It confirmed a growing realization that, even under controlled decompression conditions, bubbles still form in the circulation, even though the decompression tables had been designed to prevent this ffom happening. Secondly, bubbles form first in the arterioles, whereas theory predicts that they should appear first in the venules, where the partial pressure of nitrogen, as it leaves the accumulated stores in the tissues, must be highest. This 'arterial paradox' remains unexplained in physical terms, but was clearly established as fact by the work of the Oxford High Pressure Group. One of the developments initiated there, mainly by the work of S. Daniels, was the development of a pulse-echo ultrasound imaging technique, by which bubble formation in the circulation could be visualized directly. This technique confirmed the phenomena of arterial bubble formation and distribution in the animal experiments, and has been used to show that bubble formation occurs in divers under any practicable decompression conditions. These double-dive studies, and the importance of vascular bubble redistribution (rather than formation in the first instance), were an important part of the evidence which has led to revision of the standard decompression tables, and also to new regulations, adopted by the Navy and the British SubAqua club to control the practice of repeated dives.
The mechanism by which simple lipid-soluble substances produce anaesthesia has interested pharmacologists ever since the close relationship between the oil-water partition coefficient of volatile organic compounds and their potency as anaesthetic agents was described by Overton and Meyer at the turn of the century. Their findings were generally assumed to imply that the site of action of the anaesthetic agents must be a lipid constituent of the cell, most probably the plasma membrane, but Pauling had suggested in 1961 an alternative theory, namely that formation of hydrates, in which the anaesthetic molecules became surrounded by a shell of ordered water molecules, could account for anaesthesia by a mechanism tantamount to the freezing of a layer of water adjacent to the cell membrane. For the anaesthetics studied hitherto, hydrate dissociation pressures correlated very closely with lipid solubility, and either property correlated very well with anaesthetic potency, so the two theories could not easily be distinguished experimentally. The Oxford group were able to make very precise measurements of anaesthetic potency, including many very weakly active compounds which produced anaesthesia only under hyperbaric conditions. They showed that certain highly fluorinated compounds, such as CF4 and SF6 fitted exactly with the lipid solubility theory, but were much weaker as anaesthetics than predicted from the hydrate theory, which was no longer tenable. A second important discovery, in 1971, was that of pressure reversal of anaesthesia. Johnson and Flagler had observed in 1951 that inhibition of bacterial luminescence and immobilization of tadpoles by alcohols could be prevented by increasing the hydrostatic pressure, but the significance of this finding went largely unnoticed. The Oxford group showed that newts, which had lost their righting reflex in response to addition of various anaesthetic drugs to their water, were instantaneously restored by an increase in hydrostatic pressure by about 100 atmospheres. Later the same was shown to be true with mice anaesthetized with gaseous agents, when the chamber pressure was raised with helium. Quantitative measurements of the pressure/anaesthesia relationship led the group to conclude that the reversal phenomenon could not be explained in terms of 'squeezing the drug molecules out' of the lipid phase, as the lipid: water partition coefficients were not, in general, very sensitive to pressure. Instead, they proposed the 'volume expansion theory' which attributed anaesthesia to a small expansion (approximately 0.4%) of the volume of a critical lipid phase of the cell. Hydrostatic pressure appeared to work by compressing this phase back to its normal volume. The volume expansion theory gave a much clearer physical interpretation of the Overton-Meyer correlation than had been possible hitherto, and its beguiling simplicity did much to rekindle interest in the old question of how anaesthetics 'work'. Subsequent studies, partly in Oxford and partly elsewhere, suggested that the theory was over-simple; in particular, it was found that not all species behaved in the same way. Paton's group found with shrimps, for example, that pressure tended to enhance rather than reverse anaesthesia. The interpretation put on this entailed something of a conceptual U-tum, as the explanation proposed was that pressure tends to exert an indirect anti-anaesthetic effect in most species (though not in shrimps), and this, as well as the direct reversal of the volume expansion, can contribute to the pressure reversal phenomenon. It is known that pressure per se can induce hyperexcitability of the central nervous system in unanaesthetized animals and in man (see below), and this undoubtedly complicates the interpretation of the pressure reversal data. The question of the site of action of anaesthetic agents remains controversial.
The effect of high pressure per se on the central nervous system -the high pressure neurological syndrome or HPNS -results in convulsions, and this is now thought to determine the ultimate limit for deep-sea diving. The Oxford High Pressure Group was among the first to study this phenomenon in detail, and to show that HPNS could be avoided by the use of certain anticonvulsant drugs, such as mephenesin.
Studies on cannabis
In setting up the research group in Oxford to work on the pharmacology of cannabis, Paton's aim was simply to obtain more information about the active principles of crude cannabis, their metabolism and pharmacokinetic properties, and their effects at the biochemical and physiological level. His view was that any proposal to legalize cannabis was out of order unless the drug could be shown to satisfy the strict safety criteria that must be fulfilled by a new therapeutic agent. He set out his concerns in many articles and lectures, including several aimed at students, teachers, magistrates and politicians. He emphasized that cannabis resin is a crude mixture of many highly fat-soluble, and therefore cumulative, compounds; that tetrahydrocannabinol (THC) had been shown to cause foetal malformations in animals; that its psychological effects were known to be detrimental to performance in many tasks; that habituation had been demonstrated; that it potentiated, possibly dangerously, the effect of other depressant drugs; and that it often represented the first step on the way to a hard drug habit. These articles were written in Paton's characteristically detached style, but underlying them was a deeply felt personal conviction that to use a drug for reasons of personal gratification was simply wrong, and he hated to see young people going down that path. This was one of the few issues over which he would become really angry when challenged.
As there was at the time very little work on cannabis going on in the U.K., Paton decided to set up a small group in Oxford, enlisting the help of Edward Gill, a chemist in the department, and Roger Pertwee, a post-doc who had worked in the High Pressure Group. They began fractionating and analysing the constituents of cannabis, and examining their pharmacological properties. In 1974, the group was expanded by the appointment of a mass spectrometry expert, David Harvey, who developed methods for the detection and analysis of the major components of marijuana, and worked on the metabolism and pharmacokinetics of tetrahydrocannabinol (THC). The use of mass spectrometry to address pharmacological problems was new, and Oxford was the first pharmacology department to possess such an instrument. A neurochemist, David Wing, joined the group later. A good deal of published work came from this laboratory, including the identification of some hitherto unknown active constituents of cannabis resin, and the elucidation of the main metabolic degradation pathways of THC. They also developed simple assays for cannabinoid activity in mice, based on effects such as hypothermia, catalepsy and prolongation of barbiturate sleeping time. On the chemical side, however, larger groups elsewhere were hard at work, and the contribution of the Oxford laboratory was somewhat overshadowed. The technique that they developed for assaying THC in plasma remains, however, the most sensitive available, and with it they were able for the first time to measure the very low plasma concentrations of THC that are achieved after pharmacologically effective doses of the compound. With respect to the mechanism of action of cannabinoids, neither the Oxford group nor any other at that time made much significant progress. The high lipophilicity of cannabinoids seemed to point to an anaesthetic like mode of action, even though the rather precise structural requirements for cannabinoid action suggested something more specific. In retrospect, it seems surprising that they did not embark on binding studies, which in the late 1980s were to show clearly the existence of a specific cannabinoid receptor, later to be fully characterized and cloned.
Though a lot of good work came out of the cannabis group, it failed to make a real impact on the field, suffering from a lack of co-ordination and direction, which it was simply not in Paton's nature to provide.
Paton's rigid opposition to cannabis legalization seemed to many of his colleagues to have taken on a crusading quality that was out of tune with the analytical style of his science. It was one of the few issues over which he took criticism badly; on other topics he would take up the challenge with enthusiasm and cheerfully acknowledge when he had lost a round. It was, perhaps, the one false note in his professional life.
P u b l ic se r v ic e
Wellcome Trust
Paton became a Trustee in 1978, and served until 1987. He was recruited on the strength of his knowledge of physiology and pharmacology, to maintain the disciplinary balance of the Board of Trustees. His period of service coincided with a rapid growth in the financial strength of the Trust, and a corresponding growth in its importance as a research-funding charity. Thus, its evolving scientific programme and its increasing financial base were the main preoccupations of the Trust during the period when Paton was a Trustee. A third concern, particularly dear to his heart, was the organization of the Wellcome Institute for the History of Medicine, described above.
In 1978 the Wellcome Trust was the sole shareholder in the Wellcome Foundation, and all of its funds came from the profits of that company. The funds available were substantial, but modest by comparison to those of the Medical Research Council and other medical research charities. The Trustees felt that more could and should be done to support medical research in the UK, and therefore set about increasing their income. This led to the scientific members of the board becoming increasingly involved in the Foundation's business. The Foundation, from its earliest days under Henry Wellcome, had made a point of recruiting top-class scientists to run its research. They did not always agree, and Paton and the other Trustees found themselves caught up in a rather public and acrimonious dispute between two distinguished members of the Foundation. Paton's patient efforts to mediate were unsuccessful, and within a short space of time both had departed, presaging major changes in the scientific management of the Foundation. At the same time, the Trustees were adopting a much more critical stance with regard to the return on their capital, and soon decided to sell the major part of their 100 per cent holding of shares in the pharmaceutical company, a decision that was difficult for some of the Trustees to support. Paton was fairly neutral on this point, and content to be guided by the strong financial case for change.
One aspect of the work of the Trust to which Paton was particularly committed was the support it gave to the history of medicine. At a time when the resources were insufficient to support as much basic research as the Trustees would have liked, Paton often found himself in a minority when it came to discussions about the Wellcome Institute for the History of Medicine and the Wellcome Library. Though these had grown to a level of pre-eminence among such institutions in the U.K., there was a feeling that it should really be the responsibility of academic institutions, rather than medical research charities, to support them. Their apparent autonomy and lack of accountability to their paymasters did not altogether help, nor did the fact that they were not strongly inclined to take an interest in medical history beyond the end of the nineteenth century. Paton was passionate about the usefulness of history, and very effective in arguing this case to his fellow Trustees, so that the Institute and Library continued to receive generous funding. He was also instrumental in strengthening the Institute's commitment to contemporary medical history, and building up its contemporary medical archive collection. It was largely through his initiative that the records of bodies such as the British Pharmacological Society, the Physiological Society and the Research Defence Society came to be catalogued and stored in this archive, along with the papers of many working scientists. His own papers, meticulously collected over the whole of his working life, and amounting to 29 bulging boxes, are fittingly among this collection.
Research Defence Society
Paton served as Chairman of the Research Defence Society from 1972-77, and delivered the Paget Lecture in 1978. This was a time of rising public concern about the use of animals in research, and growing pressure to update the Cruelty to Animals Act of 1876. In 1973, an amendment came before Parliament, requiring that no experiment on an animal should be performed if its purpose could be achieved by alternative means. The R.D.S. mounted an effective campaign against this amendment, which was not enacted. In the ensuing few years, the antivivisectionist bodies progressively stepped up their campaign, and a variety of Private Member's Bills, aiming to curtail animal experimentation, came before Parliament. The R.D.S. was kept very busy in tracking and countering them, and Paton, in particular, along with the President, Lord Halsbury, played an important role in this. In one House of Lords debate, a list of supposedly cruel and unnecessary forms of animal experimentation was presented, which Paton later demolished in a point-by-point criticism, as an example of what he most despised: suggestio falsi et suppressio veri.
These wranglings eventually culminated in a completely new Act in 1984, which succeeded in achieving tighter control without hindering animal experiments for which a real need could be demonstrated.
His work with the R.D.S. stimulated Paton to write a remarkable book, Man and Mouse (10), first published in 1984 and revised in 1993. In this, he sets out for the lay reader all of the key issues surrounding the debate on animal experimentation, starting with philosophical questions about the distinction between man and animals, discussing the question of animal rights and 'speciesism', describing the kinds of animal experiments that are actually done, evaluating their usefulness in terms of alleviation of human suffering, and finishing with a detailed account of the origins and nature of the antivivisectionist movement. This book displays Paton at his best. It is written with elegance and clarity, and tackles head-on the important issues dividing experimenters from their opponents. The facts are set out, and Paton gives his own judgement -and reveals his own uncertainties -in an honest and objective way, which makes a refreshing change from the emotional polemics preferred by many debaters in this field.
Other public responsibilities
Paton was active in several scientific societies, including the Physiological Society, of which he was Secretary from 1954 to 1956. To alleviate the tedium of reading out after dinner the formal minutes of the previous meeting, he took refuge in humour. For example: 'The discussion on Communication 3 foreshadowed an ominous future for the unfortunate lungfish, which has even more gigantic nerve fibres than the squid, with the additional disadvantage that physiologists can pack it in mud and send it through the post.'
Paton served as a Rhodes Trustee, with a spell as Chairman, from 1968 to 1987. In this capacity he was instrumental in making a large donation to The Royal Society to mark the presidency of Lord Florey, who had earlier been a Rhodes Scholar, and also in making a substantial contribution to support the creation of the Chair of Clinical Pharmacology at Oxford.
In 1970, Paton was asked to chair a committee set up by the Joint Racing Board to advise on measures needed to control the doping of racehorses, and to bring order into the profusion of committees and other bodies which had sprung up. To his friends, the idea of Bill, with his scholarly and precise mind, and somewhat ascetic approach to life, communing with the grandees of the betting world, seemed unlikely, but the relationship worked very well, and the resulting Paton Report, published in 1971, established a new, much simpler system controlled by a single committee, the Horserace Anti-Doping Committee. Paton insisted that this should have a strong contingent of scientists with knowledge of the drugs and the way in which they were used. He declined the chairmanship of the new group, but was an active member of it for some years. Paton was honoured with a CBE in 1968 and was knighted in 1979.
Personality and style
Bill Paton was not an easy man to know. He was generally reticent about his opinions and beliefs, even though he cared deeply about many things. The strong sense of duty, which clearly came through to him from his family background, was expressed in many ways, particularly through the different causes and public responsibilities that he took on. When he felt that something deserved his support, he would devote himself to it unstintingly, whether it was a scientific institution such as the Physiological Society, a pressure group such as the Research Defence Society, or a funding body such as the Medical Research Council or Wellcome Trust. He was generous in giving money, as well as time, to many of these causes. He had no gift whatever for political manoeuvring, and in a videotaped memoir* he comments on his own naivete up to the time that he moved to Oxford. He had, for example, never thought of applying for a research grant, but simply relied on the financial support of U.C.H. or the Royal College of Surgeons to keep his research going. Though he had perforce to master some of the intricacies of university politics at Oxford in order to keep up support for the department, it was certainly not his forte, and most of his colleagues would say that the guilelessness never left him. He never sought to establish a power base, and as a result, made very few enemies.
Scientifically, it is fair to say that Bill was essentially a loner, many of his publications, including some of his best ones, are solo efforts.
An individualist himself, he preferred others also to define their own problems, and plan their own individual approaches. He would be generous with his time when asked to comment on or criticize a piece of work, but rarely gave unsolicited advice. He chose his coworkers on the basis of their ability as he saw it, often through personal contacts and recommendations, and would generally be completely open-minded about what they chose to work on, though he would make a few general suggestions if they seemed to be at a loss. His own range of interests and knowledge was so broad that he was happy to support anything so long as the scientific basis seemed to him sound. He would throw in ideas if asked, but generally preferred people to plan their own projects. The result was that the laboratory at any one time would usually contain four or five research fellows working on unrelated projects, usually with a lot of discussion going on, but little actual collaboration or teamwork. Discussions with Bill were always valuable. He was able to articulate problems with great simplicity and clarity, so that it usually became quite obvious where the difficulty lay, and what needed to be done next. He was particularly good at extracting conclusions and hints from experimental data that others might have given up on. On many occasions students who had shown him distinctly unpromising fragments of data would emerge looking much more cheerful after Bill had scrutinized the trace for a while, made a few measurements, jotted down the numbers and made a few calculations. Books and book-collecting were Bill's special passion, acquired during his student days, and gaining strength as the years passed. In a light-hearted essay published in 1988, he described it in terms of an addiction, involving a steady escalation of the dose needed to achieve satisfaction, and progressively increasing financial outlay. His collection, which grew to occupy a large part of his house in north Oxford, as well as his office in the Pharmacology Department, contained many rare items, mainly with scientific and medical associations, the pick of which he left to the Wellcome Library when he died.
One episode which is worth mentioning, as it encapsulated so many of Bill's talents and personal interests, was his contribution to The Royal Society's Tercentenary Soiree, held on 16 November 1965, and attended by the Queen Mother and the King of Sweden. Bill had a deep interest in the history of science, and was for several years an enthusiastic editor of the Society's Notes and Records, so he was a natural choice as a member of the Soiree Committee set up to organize this important event. Bill himself was responsible for organizing two exhibits, one on the history of blood transfusion, and the other on some of the musical and acoustical experiments reported to the Society in the seventeenth century. The demonstration centred around a peculiar musical instrument known as the marine trumpet, which had featured in the early Philosophical Transactions. The marine trumpet is a large wooden monochord instrument, played by bowing, and equipped with a special shaking bridge, which makes it sound a mournful honking note, somewhat like a brass trumpet. The string is lightly stopped at points that cause it to vibrate segmentally, so that the notes that it can deliver are, like those of the brass trumpet, restricted to exact harmonics, some of which are out of tune with respect to the diatonic scale. The trumpet owes its name to its 16th-century inventor, Marino, not to any nautical connection. Bill was in his element with this combination of physics, musical theory and history, and arranged for an exact replica of a marine trumpet from the Victoria and Albert Museum to be built in the workshop of the Pharmacology Department. Over several months, members of the Department became used to the loud and forlorn notes emerging from Bill's office, and to the bank of oscilloscopes that he had set up in order to show how precisely out of tune they were. For the Royal Society Soiree, oscilloscopes would have been out of place, and instead the demonstration used a flame harmonic analyser consisting of perforated tube fed with gas, into one end of which the sound was introduced. As the gas column vibrated, the size of the gas flames along the row of perforations showed a sinusoidal modulation representing the segmental vibrations of the gas as a replica of those of the trumpet string. It fell to Bill, as one of the main organizers of the Tercentenary Soiree, to escort the Queen M other around the exhibits; what she thought of the marine trumpet and the dancing flames is not recorded.
Despite his many professional commitments, Bill remained firmly attached to his family and home, and avoided travelling if he could. He and Phoebe bought the house next door to them in Oxford to accommodate Phoebe's elderly mother and disabled brother when it became difficult for them to live independently. This was a considerable burden, and greatly limited their freedom to travel or take holidays together, but it would not have been in their nature to act any differently, much less to complain.
Overall, B ill's life was a very contented one. He recalled his early years at home, school and university, as well as his later professional life, with affection and appreciation. His happy marriage to Phoebe was a linchpin in his life, and despite the burden of chronic ill health, he remained cheerful and enthusiastic, with an intellect that showed no sign of decline as he grew older. He died suddenly at home from a stroke. The frontispiece photograph, taken by Walter Bird, was given to the Royal Society in 1967 and reproduced with the kind permission of the Godfrey Argent Studio.
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